ESC Premium Access

Impact of cumulative burden of body mass index and waist circumference on risk of atrial fibrillation: an analysis of 3,700,000 participants who underwent 4-year consecutive annual health examination

Presentation

About the speaker

Doctor Tae-Min Rhee

Seoul National University Hospital, Seoul (Korea (Republic of))
0 follower

160 more presentations in this session

The impact of abnormal conduction zone on outcomes after catheter ablation for atrial fibrillation

Speaker: Associate Professor T. Mine (Hyogo, JP)

Thumbnail

Thromboembolic risk of movable type left atrial appendage thrombi in patients with atrial fibrillation under widespread use of anticoagulants

Speaker: Doctor M. Sugitani (Nishinomiya, JP)

Thumbnail

Rate and rhythm control treatment in the elderly and very elderly patients with atrial fibrillation: an observational cohort study of 1,497 patients

Speaker: Mr T. Klamer (Amsterdam, NL)

Thumbnail

One year outcome and analysis of peri-device leak of left atrial appendage occlusion devices

Speaker: Doctor M. Mansour (Montreal, CA)

Thumbnail

Risk prediction of atrial fibrillation and its complications in the community using high-sensitivity cardiac Troponin I: Results from the BiomarCaRE Consortium

Speaker: Doctor C. Boerschel (Hamburg, DE)

Thumbnail

Access the full session

Atrial fibrillation e-posters

Speakers: Doctor T. Rhee, Associate Professor T. Mine, Doctor M. Sugitani, Mr T. Klamer, Doctor M. Mansour...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Atrial fibrillation and anticoagulation: the patient with reduced kidney function – how to prevent stroke.

29 August 2021

ESC Premium Access

Association of daily coffee consumption with cardiovascular health - Results from the UK Biobank

27 August 2021

ESC Premium Access

Effectiveness and safety of edoxaban in atrial fibrillation patients from the ETNA-AF global registry

27 August 2021

This platform is supported by

logo Novo Nordisk